MABs Successfully Treat Immunotherapy-Related Myocarditis MABs Successfully Treat Immunotherapy-Related Myocarditis

Alemtuzumab and abatacept were both successfully used in patients with steroid-refractory myocarditis that developed during treatment with immune checkpoint inhibitors.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news